Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
China Set to Exit Deflation Cycle in Early 2026, ANZ Analysts Say
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Asian Stocks Surge as U.S.-Iran Ceasefire Deal and Samsung Earnings Boost Market Confidence
Asian Currencies Hold Steady as Middle East Ceasefire Doubts Weigh on Markets
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Italy's Service Sector Contracts for First Time in 16 Months Amid Rising Costs and Weakening Demand
Bank of Japan Governor Signals Accommodative Stance Amid Negative Real Rates
U.S. Stock Futures Surge as Trump Announces Iran Ceasefire, Oil Prices Plunge
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Sterling Slides as Dollar Holds Firm Amid U.S.-Iran Tensions
Bill Ackman Eyes New Fund to Bet Against Market Complacency 



